Susan Sutherland

机构：University of Birmingham · ORCID：0000-0002-2428-4322

发表论文 25 篇 · 总被引 1893 次 · h-index 13

代表论文

• Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) (2010 · Journal of Clinical Oncology · 被引 853)
• Bisphosphonate Associated Osteonecrosis of the Jaw (2009 · The Journal of Rheumatology · 被引 281)
• Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. (2008 · PubMed · 被引 204)
• Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. (1995 · PubMed · 被引 152)
• Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results (2006 · Journal of Clinical Oncology · 被引 115)
• Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102) (2012 · Journal of the National Comprehensive Cancer Network · 被引 107)